CEOCFO:Mr. Useche, would you tell us the focus of Relevium Technologies
today, how long have you been with the company and what attracted you?

Mr. Useche:
The initial strategy of Relevium was to consolidate the health and wellness
space in eCommerce. We found that there were a lot of entrepreneurial brands
that cater to that marketplace, whether it is nutrition, supplements or
skincare that only sell their products online. We identified a pipeline of
businesses between $2 and $20 million of revenue, highly profitable, running
with an EBITDA of 20% to 30% and we saw a real opportunity to consolidate
brands and create value. We acquired our first company last year around this
same time of the year, Bioganix, which is an online brand of nutraceutical
products. Ever since, we are adding value by focusing on brand development,
product extension, geographic expansion and marketplace diversification. We
are currently expanding our brand to the European market, which we
anticipate launching this month. We have expanded the product line through
the introduction of trending products and through partnerships that provide
exclusivity through science-based ingredients and formulations. One of our
main strengths is our ability to forge different partnerships. In the case
of Bioganix we forged a couple partnerships with companies that can provide
us with a specificity in formulation services for our products to have a lot
of medical research behind them, so we could then launch products that are a
little bit different from what we are seeing out there.

I have been with the
company as CEO since November 2016 and in addition to being an investor in
the IPO, my initial attraction was the opportunities in the health and
wellness market.

CEOCFO: Was Bioganix
an acquisition or is that an outfit you are partnering with?

Mr. Useche:
It was 100% acquisition.

CEOCFO: Are you
partnering with people to deliver the products to market?

Mr. Useche:
This is in fact a key value-added focus to our strategy. We know our
strengths in the digital space and we seek to partner with organizations
that provide unique and trusted ingredients as well as formulation
capabilities. When we acquire a new brand, we focus on the introduction of
exclusive products that can be introduced directly into the channel. The
fact that these are exclusive formulations translates quickly into higher
margins and lower media buying costs. One of such partners is Tersus Life
Sciences, a supplement company located in Bonita Springs, Florida that
developed the science behind Provinal®–an
ultra-purified form of Omega 7 (Palmitoleic acid), the next generation of
Omega fatty acids that have been shown to possess broad properties to combat
diabetes, metabolic syndrome, and atherosclerosis. We are currently in
production of two exclusive formulations, one that supports the most
important markers of cardiac health and another that supports overall eye
health.

Last year we started
looking at the health benefits of cannabinoids and at the possibility of
developing new formulations. Our initial approach was strictly from a health
support and science point of view and not as a strategy for capital markets
promotion. This was the how our team began to focus on the potential health
supporting cannabis market.

One of the challenges we
faced in the exploration process, in addition to regulatory issues in the US
and Canada, was the supply chain. The marketplace is currently flooded with
hundreds if not thousands of unproven products without any traceability on
the quality and source of the key ingredients. Although we do not consider
ourselves to be a “Cannabis Company”, we do believe that cannabinoids will
provide our customers with added health benefits to address things like
inflammation, pain, anxiety and even sports recovery.

In view of these quality
and sourcing challenges we decided to create our subsidiary Biocannabix
Health Corporation, a vertically integrated, science-based developer of
nutraceutical and other medical grade consumer products focused specifically
on the cannabinoid market. We are currently cementing the right partnerships
to ensure that Biocannabix becomes a leading consumer health product company
in the space.

This is where we are
today. We remain focused in growing our online brand portfolio through
acquisitions in our core business and we are also working hard to build
Biocannabix into a fully integrated cannabis company that would grow,
process and develop consumer packaged goods for medical purposes.

CEOCFO:Why the focus on nutraceuticals, sports nutrition and nutria-cosmeceuticals?
What opportunities present themselves that would not be there in some other
area of health or technology?

Mr. Useche:
One of the reasons why we are focused on nutraceuticals is because the key
members of the executive committee come from the nutraceutical world. On our
board for example, all of the directors come from the Pharma/nutraceutical
space. Dr. Tina Sampalis, M.D., Ph.D., one of our directors, is one of the
inventors and developers of the IP behind krill oil as a source of omega
fatty acids, the product that gave birth to Neptune Wellness. In terms of
nutrition, Abis Hussain, our Chief Marketing Officer and several of our
advisors come from the world of sports nutrition.

In terms of the
opportunities we see in this business is the integration of cannabinoids in
terms of trusted consumer products that support health and wellbeing. We
traveled across the US and Canada, looking at what products were available
for consumers today in this space and trust is a major issue. Although there
are many things being offered, I do not know necessarily that what I am
taking is exactly what I am told I am taking. The source and application of
the product seems to be without any real understanding of the health
concerns that a consumer may want to address. For example, we probably met
sixteen different CBD companies and we found that the application, quality,
source and purpose of the product is sort of generic and the way that the
product is packaged, it is difficult to know how the product should be used.
We visited some large operations and we also visited mom and pop shops that
are very successful.

We have also been
extremely thankful to meet a few organizations in the US as well who really
know and understand cannabis and their patients. These organizations have
been working with patients to deal with pain, cancer and other ailments, and
through experience and a real passion for their patients, they have been
able to develop formulations and applications that have a positive impact on
people’s health. What we are hoping to do here with Biocannabix and why we
think there is an opportunity in terms of nutraceuticals is that we can
formulate product, leverage the know-how that exists on cannabis products
for medical purposes and then do formulations for things that we already
know. For example, turmeric or curcumin for inflammation; we can formulate
with an omega 3 product for heart conditions. The idea behind that is to
bring existing science and formulate it into research and come out with
trusted products where consumers will look at that brand and say, “I know
these guys know what they are doing, and I can feel safe that the product
they make is good and well formulated and it is going to be good for me”. We
will be looking for acquisitions as well in the very near term because this
also opens distribution channels.

CEOCFO:Do you invest heavily in product development?

Mr. Useche:
We rely on members of our executive team but mostly we rely on our
formulation partners. Companies like Tersus Life Sciences and Neptune
Wellness Solutions (TSX / NASDAQ: “NEPT”) out of Montreal, in addition to a
wide network of CMOs in North America and Europe.

CEOCFO:Your Bioganix products are available through Amazon and Walmart. Was
that distribution developed by Relevium Technologies? Would you tell us
about your approach to building relationships with distributors, sales and
marketing?

Mr. Hussain:
When we acquired Bioganix, the products were only sold through Amazon.com
(USA) so that became the core business in the beginning. The whole message
of Relevium has been in health and wellness,and we have been
expanding our catalogue ever since and investing in branding and
development. The whole approach is to put the best product out there, so we
came up with a plan on how we could take Bioganix to different marketplaces
and not just sell on Amazon. The first thing was to expand on Walmart.com,
so we launched Bioganix Gold line last week on Walmart.com. We are also in
talks with Costco, Target and Walgreen’s about carrying products. In terms
of marketplaces on-line we are constantly expanding, and the reason is that
we have spent so much in development that now we really want to take our
product out there into the market and tell people that we carry the best
products and that is what they need in their household. We wanted to make it
family-friendly. In terms of a marketing approach, my background is from the
digital space and I have been in the online space for about 10 years. The
goal is to play in the eCommerce space, which means launching in all the
other available platforms in the US. Then we are slowly moving along the
lines of expansion in Europe, so we are going live in the United Kingdom in
the next couple weeks and we should be live with some of our Bioganix
products in the UK.

CEOCFO: Who is
putting it out there?

Mr. Hussain:
It is on Amazon. From there we will go to Amazon Germany, Amazon France,
Amazon Spain, so the whole European expansion will be through Amazon. The
same thing we are trying to do with Walmart, wherever they are selling as
well as India.

CEOCFO: Are you
strictly on Walmart online store or on the shelves as well?

Mr. Hussain:
Our deal with Walmart is to launch our brand online first and then if the
brand is well received and we see consistent growth in sales, then we will
automatically be sold on the shelves. Bioganix wants to be a global brand
available in all the marketplaces and that is why we are relying on the
marketplaces. We also sell our product through our native website at
Bioganix.com. The way we do that is we do media buys. We buy advertising
spots on Google, and social media such as Facebook. We also look for people
who can endorse our products. We are looking at people who can really take
it and like it and use it, then give us an honest opinion. Frankly there has
been a positive reception in the market for our Bioganix products. When we
do advertise we want the buyer to come to our own website and buy. We do not
send them to Amazon or Walmart. We do have marketing strategies that cater
strictly towards Amazon and Walmart and then there are strategies outside
the marketplace, which is through buying search engine traffic and social
media traffic and diverting them to our website.

CEOCFO:How is consumer awareness?

Mr. Useche:
Part of our strategy is brand development. Bioganix was initially an Amazon
centric brand and now it is gaining awareness through active marketing and
branding campaigns outside of the marketplace. Our brand is primarily
popular amongst women and we are now targeting larger segments of the
population by understanding their own needs and buying drivers.

CEOCFO: Is your
advertising strictly online? Do you buy AdWords? Do you do television and
radio or print?

Mr. Hussain:
We are looking to do some ad buys in television like an infomercial but not
print media now. I have a plan to go with a health magazine, such as
Bodybuilding.com Magazine, down the line, maybe early next year. However,
for now we are strictly AdWords, social media.

CEOCFO: Are you still
looking for acquisitions?

Mr. Useche:
Indeed. This is still a pillar of our strategy. The beauty of growth by
acquisition is, if structured properly, there is the access to new product
lines, markets and different sets of skills that we can add to our company.
All we can say at this time is that we are currently looking at a handful of
possible transactions. We are hoping to structure something with at least
one of them in a way that is beneficial to the company from a strategic
point of view, structured in a way that is also beneficial to our
shareholders. We started the new fiscal year in July and we have targeted to
conclude at least one accretive transaction in the near term.

CEOCFO:What type of investments do you look for? Are you looking for brands
and products where an infusion of cash would take them to the next level?
Are you into product tweaking and development? Are you looking for
opportunities where your management experience and expertise can make the
difference?

Mr. Useche:
There is a little bit of everything that you mentioned. For example, we are
looking at a transaction right now that is based in Europe so there is a
particular know-how about the European market. As we are expanding to the
European market, we know that we are going to acquire some local know-how.
By acquiring this company, we acquire know-how, but we also acquire two
product lines that are not currently in our portfolio. What we look for in
this case is a strategic transaction. We have another transaction where an
investment in cash will make a big difference in terms of setting the
company to go to the next stage. The product that the company has is very
much in line with our health and wellness product portfolio. It is in an
area that is very popular and in high demand. I think we can add value that
way. On a transaction basis, we always look to make sure that we have a
strategic component to why we are doing that transaction, but we do not only
look to add revenues. Obviously that is how we derive value, but we also
look to a point of view of what it is that we are going to need in the
short-term that is going to take us to the next step, and instead of doing
it ourselves, why don’t we find the right vehicle to take us there and
acquisitions are one good way that I think we can do that.

Mr. Hussain:
We have a series of weight-loss products and not just one. We are more
focused toward natural supplements, plant-based. Some of them are highly
reviewed products on Amazon. When we acquired the brand, we just took
whatever inventory came with it. We revisited the manufacturer as well as
the supplement facts and formulation of the products. Then again, that is
where our board brings value; most of them are from this background. As I
mentioned, we have Dr. Tina Sampalis on our board. We looked at what
ingredients we wanted to take out or add and how to make it better. Our
products are the real deal. They are not just knock-offs or something that
you can pick up on the shelf. We have put our thought processes behind them
and made sure these do not have side-effects and we’re quite proud of our
ratings on Amazon.

CEOCFO:What is your approach to management of your acquisitions? Are they run
as subsidiaries or all under one umbrella?

Mr. Hussain:
It is a little of both. One of the targets we are looking at now would be
included into an existing business unit but another one will be a new
business unit. It really depends on how we want the structure in that brand
or product and how we can create value.

CEOCFO:Do you currently have the funds in place to continue making
acquisitions and growing the company? Are you looking for investors or to
raise capital?

Mr. Useche:
As you know, Venture exchange companies continue to look for growth capital,
so we will go back to the market for growth capital. Right now, the way that
we are structuring these transactions is we do not require capital to close
a transaction, but we will need the ability to source financing to grow the
brands and to do the things that we want to do. We will go back to the
market as conditions permit us to do so.

CEOCFO:Do you attend conferences and participate in road shows?

Mr. Useche:Investor conferences we
did last year. In terms of the summertime, it has been a bit quiet, but we
have a lot of work to do to gear up for September. We will go out on road
shows this fall and attend investor conferences. We do attend industry
events simply because we want to make sure that we are always on top of
things. For example, early this year, we attended Supply Side West. We
attended ASD in Las Vegas. We will go and attend industry specific
conferences just to make sure that we keep a good ear and temperature on
what is new, what are the new ingredients, what is trending and so forth.

CEOCFO:In closing, address our readers in the business, investment and health
communities. Why is Relevium Technologies an important company today?

Mr. Useche:
The value that we add is that we are very focused on eCommerce and digital
marketing and quicker and more effective ways to launch new products. Within
the space of health and wellness, most consumer-packaged goods are delivered
through brick and mortar outlets such as pharmacies and supermarkets. We
believe that we can add a lot of value leveraging the go-to-market
effectives of online business to build brand equity and then combine this
with brick and mortar.

If we went strictly
through regular channels, for example, if we were launching a new product,
by the time the product was close to being on the shelf and go then through
the whole cycle, it could be a year before we know what is going on for us.
If we are doing it online, we can read minute by minute what is happening in
that marketplace for that distribution channel.

Relevium combines
eCommerce, science and formulation partners, through existing brands and can
leverage unique health benefits from cannabis. The combination of all these
components make us an interesting proposition and we believe creates a very
quick and reactive company that will be able to execute quite well in terms
of reaching out to consumers. We are not saying that we will not enter brick
and mortar retail; in fact we think it will play an important role in making
sure that good products with science backing them up will reach consumers
faster in a more efficient way.

“The value that we add is that we are very
focused on eCommerce and digital marketing and quicker and more effective
ways to launch new products… We believe that we can add a lot of value
leveraging the go-to-market effectives of online business to build brand
equity and then combine this with brick and mortar.”- Aurelio Useche